Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Investigating the role of FOS/AP-1 in OnF reprogramming during tumor intiation

ABSTRACT: Investigating the role of FOS/AP-1 in OnF reprogramming during tumor intiation

PROVIDER: PRJNA1095522 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR28536422.fastq.gz	Fastqsanger.gz
	SRR28536423.fastq.gz	Fastqsanger.gz
	SRR28536424.fastq.gz	Fastqsanger.gz
	SRR28536425.fastq.gz	Fastqsanger.gz
	SRR28536426.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 12

Similar Datasets

Investigating the role of FOS/AP-1 in OnF reprogramming during tumor intiation

Project description:To investigate the role of FOS/AP-1 in early OnF reprogramming, we blocked its activity during tumor intiation by overexpressing a dominant negative form of FOS.

2024-10-17 | GSE263056 | GEO

Investigating the role of YAP and FOS in driving OnF reporgramming during tumor intiation

Project description:To investigate the role of YAP and FOS in early OnF reporgramming, we knocked down either gene during tumor intiation induced by APC depletion.

2024-10-17 | GSE263047 | GEO

Investigating the role of YAP and FOS in driving OnF reporgramming during tumor intiation

Project description:Investigating the role of YAP and FOS in driving OnF reporgramming during tumor intiation

| PRJNA1095509 | ENA

Transcriptional profiling of intestinal organoids following ectopic expression of YAP (S6) +/- FOS.

Project description:To elucidate the roles of YAP and FOS/AP-1 in driving OnF reporgramming, we tested the effects of their ecotpic expression in healthy intestinal organoids. The sequential overperession recapitulates the chornnology of deregulation of both axes during CRC evolution.

2024-10-17 | GSE263050 | GEO

AP-1 inhibition in DRG neurons by A-Fos dominant negative construct

Project description:Prior analysis suggsted that that AP-1 TFs play a role in expression of specific B2-SINE following in-vivo nerve injury. We thus sought to experimnetally test the role of AP-1 transcription factors in upregulation of B2-SINE RNA expression in DRG neurons. Neurons were transduced with PHP.S-AAV vectors expressing either A-Fos (dominant negative construct that targets Fos-interacting transcription factors), GFP control or were left untransduced. RNA was extracted 7 days later and analyzed to identify effects on B2-SINE expression and known AP-1 targetted mRNAs.

2025-05-16 | GSE230719 | GEO

Investigating the role of USP22 in reprogramming

Project description:Investigating the role of USP22 in reprogramming

| PRJNA934088 | ENA

Transcriptional profiling of AKSP tumoroids following knockdown of either YAP or FOS.

Project description:To elucidate the role of YAP and FOS in sustaining the OnF state in davnaced CRC, we knocked down either gene in AKSP tumoroids.

2024-10-17 | GSE263055 | GEO

The FOS/AP-1 regulates the expression of selective genes involved in ovulation and luteinization in human granulosa cells

Project description:FOS, a subunit of the activator protein-1 (AP-1) transcription factor, has been implicated in various cellular changes. In the human ovary, the expression of FOS and its heterodimeric binding partners JUN, JUNB, and JUND increases in periovulatory follicles. However, the specific role of the FOS/AP-1 remains elusive. The present study determined the regulatory mechanisms driving the expression of FOS and its partners and functions of the FOS/AP-1 using primary human granulosa/lutein cells (hGLC). hCG induced a biphasic increase in the expression of FOS, peaking at 1-3h and 12h. The levels of JUN proteins were also increased by hCG, with varying expression patterns. Co-immunoprecipitation analyses revealed that FOS is present as heterodimers with all JUN proteins. hCG immediately activated PKA and p42/44MAPK signaling pathways, and inhibitors for these pathways abolished hCG-induced increases in the levels of FOS, JUN, and JUNB. To identify the genes regulated by FOS, high throughput RNA sequencing was performed using hGLC treated with hCG ± T-5224 (FOS inhibitor). Sequencing data analysis revealed that FOS inhibition affects the expression of numerous genes, including a cluster of genes involved in the periovulatory process such as matrix remodeling, prostaglandin synthesis, glycolysis/gluconeogenesis, and cholesterol biosynthesis. qPCR analysis verified hCG-induced, T-5224-regulated expression of a selection of these genes. Consistently, T-5224 attenuated hCG-induced increases in metabolic activities and cholesterol levels. This study unveiled potential downstream target genes of and a role for the FOS/AP-1 in granulosa cell metabolic changes and cholesterol biosynthesis in human periovulatory follicles.

2021-02-10 | GSE166443 | GEO

Role for AP-1 transcription factors (c-Jun, c-Fos) in prostate cancer progression and clinical outcome of prostate tumor

Project description:In our investigations of the molecular pathways of prostate tumorigenesis in Nkx3.1; Pten mutant mice using gene expression profiling, we now find that the AP-1 transcription factors, c-Jun and c-Fos, are significantly up-regulated during cancer progression. Forced expression of c-Fos and c-Jun in prostate cancer cells results in increased tumorigenicity, activation of Erk MAP kinase, and enhanced survival in the absence of androgens, which are hallmarks of disease progression. In humans, Jun and Fos proteins are significantly up-regulated during prostate cancer progression and significantly correlated with activation of Erk MAP kinase. Most notably, expression of Jun is associated with disease recurrence independent of other currently used prognostic indicators. These analyses reveal a hitherto unappreciated role for AP-1 transcription factors in prostate cancer progression vis-à-vis Erk MAP kinase signaling, as well as the identification of a novel marker of disease recurrence, namely c-Jun. Keywords: Stages of Prostate Cancer

2008-06-27 | GSE11836 | GEO

RNA-seq of KYAE-1 and OE19 oesophageal adenocarcinoma cells following induction of dominant negative (acidic) FOS

Project description:To identify AP-1 regulated genes in KYAE-1 and OE19 oesophageal adenocarcinoma cells we induced expression of dominant negative (acidic) FOS to inhibit AP-1 activity and then performed RNA-seq. Acidic FOS (aFOS, J Biol Chem. 1997 Jul 25;272(30):18586-94. doi: 10.1074/jbc.272.30.18586) was expressed from the pINDUCER20 vector.

2023-01-05 | E-MTAB-10334 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data